Viewing Study NCT00068393

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-05-11 @ 3:20 PM
Study NCT ID: NCT00068393
Status: COMPLETED
Last Update Posted: 2023-07-07
First Post: 2003-09-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
Sponsor: Eastern Cooperative Oncology Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Renal Cell Carcinoma View
None Renal Cell Carcinoma With Sarcomatoid Features View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sarcomatoid View
None Gemcitabine View
None Doxorubicin View
None Renal cell cancer View
None Kidney cancer View